Recurrent herpes simplex virus-1 infection induces hallmarks of neurodegeneration and cognitive deficits in mice.
Giovanna De ChiaraRoberto PiacentiniMarco FabianiAlessia MastrodonatoMaria Elena MarcocciDolores LimongiGiorgia NapoletaniVirginia ProttoPaolo ColuccioIgnacio CelestinoDomenica Donatella Li PumaClaudio GrassiAnna Teresa PalamaraPublished in: PLoS pathogens (2019)
Herpes simplex virus type 1 (HSV-1) is a DNA neurotropic virus, usually establishing latent infections in the trigeminal ganglia followed by periodic reactivations. Although numerous findings suggested potential links between HSV-1 and Alzheimer's disease (AD), a causal relation has not been demonstrated yet. Hence, we set up a model of recurrent HSV-1 infection in mice undergoing repeated cycles of viral reactivation. By virological and molecular analyses we found: i) HSV-1 spreading and replication in different brain regions after thermal stress-induced virus reactivations; ii) accumulation of AD hallmarks including amyloid-β protein, tau hyperphosphorylation, and neuroinflammation markers (astrogliosis, IL-1β and IL-6). Remarkably, the progressive accumulation of AD molecular biomarkers in neocortex and hippocampus of HSV-1 infected mice, triggered by repeated virus reactivations, correlated with increasing cognitive deficits becoming irreversible after seven cycles of reactivation. Collectively, our findings provide evidence that mild and recurrent HSV-1 infections in the central nervous system produce an AD-like phenotype and suggest that they are a risk factor for AD.
Keyphrases
- herpes simplex virus
- stress induced
- high fat diet induced
- multiple sclerosis
- traumatic brain injury
- cerebrospinal fluid
- cognitive decline
- white matter
- hiv infected
- type diabetes
- antiretroviral therapy
- single molecule
- wild type
- metabolic syndrome
- insulin resistance
- spinal cord
- lps induced
- blood brain barrier
- risk assessment